Ethyl 6,7-difluoro-2-ethylmercapto-4-hydroxyquinoline-3-carboxylate (CAS: 154330-67-3) is more than just a chemical compound; it's a meticulously engineered molecule that serves a critical function within the pharmaceutical sector. As a leading provider, NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to offering this intermediate with unparalleled quality and detailed information. This article delves into the specific chemical properties and application landscape of this vital compound, highlighting why it is a preferred choice for advanced drug synthesis, particularly for antibiotic synthesis.

The compound's physical form is a light yellow to off-white crystalline powder, a characteristic that aids in its handling and processing within manufacturing environments. Its molecular formula, C14H13F2NO3S, and molecular weight of 313.32 g/mol underscore its complex organic nature. Key physical properties such as a density of 1.38 g/cm³ and a boiling point of 402.7°C at 760 mmHg demonstrate its robust chemical profile. Furthermore, a flash point of 197.4°C indicates a good level of thermal stability, which is crucial for safe processing and storage in the pharmaceutical industry. These attributes make it a reliable choice for companies engaged in Prulifloxacin intermediate synthesis.

The primary utility of Ethyl 6,7-difluoro-2-ethylmercapto-4-hydroxyquinoline-3-carboxylate is its role as an indispensable intermediate in the synthesis of Prulifloxacin, a potent fluoroquinolone antibiotic. The high assay level of ≥98.0% ensures that it meets the stringent purity requirements essential for pharmaceutical applications, minimizing impurities that could affect the final drug's efficacy or safety. For researchers and manufacturers, understanding these chemical properties is key to optimizing synthetic routes and ensuring product consistency, supporting the broader field of antibiotic synthesis.

Beyond its established pharmaceutical applications, the quinoline-based structure of this compound, coupled with its fluorine and sulfur substitutions, makes it a subject of interest for broader chemical research. Its potential in developing new heterocyclic compounds or in exploring structure-activity relationships in medicinal chemistry is significant. By offering this compound, NINGBO INNO PHARMCHEM CO.,LTD. not only supports current pharmaceutical production but also contributes to the advancement of future therapeutic innovations, underscoring its value as a crucial fluoroquinolone antibiotic intermediate and a partner for chemical compound exploration.